Literature DB >> 20668266

Beyond PARP inhibitors: agents in pipelines target DNA repair mechanisms.

Amy Maxmen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20668266     DOI： 10.1093/jnci/djq294

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  DNA repair inhibitors: where do we go from here?

Authors:  Mark R Kelley
Journal:  DNA Repair (Amst)       Date:  2011-10-02

Review 2.  Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.

Authors:  Yanxin Lu; Yang Liu; Ying Pang; Karel Pacak; Chunzhang Yang
Journal:  Pharmacol Ther       Date:  2018-04-03       Impact factor: 12.310

Review 3.  Bioengineering approaches to study multidrug resistance in tumor cells.

Authors:  Brian Fallica; Guy Makin; Muhammad H Zaman
Journal:  Integr Biol (Camb)       Date:  2011-03-08       Impact factor: 2.192

Review 4.  Selective tumor killing based on specific DNA-damage response deficiencies.

Authors:  Michael Biss; Wei Xiao
Journal:  Cancer Biol Ther       Date:  2012-03-01       Impact factor: 4.742

Review 5.  Targeting DNA repair pathways for cancer treatment: what's new?

Authors:  Mark R Kelley; Derek Logsdon; Melissa L Fishel
Journal:  Future Oncol       Date:  2014-05       Impact factor: 3.404

6.  The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities.

Authors:  Eun-Kyoung Yim Breuer; Mandi M Murph
Journal:  Int J Proteomics       Date:  2011-01-01

Review 7.  HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies.

Authors:  Rüveyda Dok; Sandra Nuyts
Journal:  Cancers (Basel)       Date:  2016-03-29       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.